What strategies could boost TIVC's future EPS?

To enhance TIVC's future EPS, the company should focus on the following strategies:

1. Improve Revenue Growth: TIVC needs to increase its revenue to boost EPS. This can be achieved by expanding its product portfolio, entering new markets, and enhancing its marketing strategies.
2. Optimize Cost Management: The company should focus on reducing its operating expenses, which will directly impact the bottom line. This includes optimizing its supply chain, improving operational efficiencies, and controlling general and administrative costs.
3. Enhance Liquidity and Financial Health: Maintaining a strong liquidity position with a high current ratio, as indicated by InvestingPro analysis, is crucial. This will provide the company with the financial flexibility to invest in growth opportunities and reduce debt, which can negatively impact EPS.
4. Leverage New Product Developments: The commercialization of Entolimod and the expansion of the patent portfolio could lead to new revenue streams and potentially higher EPS. TIVC should prioritize the development and launch of these products.
5. Clinical Trial Progress: Initiating disease-specific clinical trials for its vagus nerve stimulation device could lead to regulatory approvals and increased sales, contributing to higher EPS.
6. Analyst Ratings and Market Sentiment: Positive analyst ratings and sentiment can attract investors and boost the stock price, indirectly influencing EPS through increased market capitalization and potential for higher valuations.
7. Strategic Partnerships: The recent expansion of the licensing agreement with Statera Biopharma indicates a positive direction. Such partnerships can bring in new technologies and markets, potentially increasing revenue and EPS.

By implementing these strategies, TIVC can work towards improving its EPS and overall financial performance.